Matching articles for "emergency contraception"
Choice of Contraceptives
The Medical Letter on Drugs and Therapeutics • May 15, 2023; (Issue 1676)
Intrauterine devices (IUDs) and the etonogestrel
implant are the most effective reversible contraceptive
methods available. Hormonal oral contraceptives,
patches, rings, and injectables are also effective...
Intrauterine devices (IUDs) and the etonogestrel
implant are the most effective reversible contraceptive
methods available. Hormonal oral contraceptives,
patches, rings, and injectables are also effective in
preventing pregnancy. When used alone, barrier and
behavioral methods generally have higher failure
rates than other methods (see Table 1). Selection of
a contraceptive method is usually based on patient-specific factors and personal preference
Choice of Contraceptives
The Medical Letter on Drugs and Therapeutics • October 8, 2018; (Issue 1557)
Intrauterine devices (IUDs) and the etonogestrel
implant are the most effective reversible contraceptive
methods available. Hormonal oral contraceptives,
patches, rings, and injectables are also highly...
Intrauterine devices (IUDs) and the etonogestrel
implant are the most effective reversible contraceptive
methods available. Hormonal oral contraceptives,
patches, rings, and injectables are also highly effective
in preventing pregnancy. When used alone, barrier and
fertility-based methods generally have higher failure
rates than other methods.
Choice of Contraceptives
The Medical Letter on Drugs and Therapeutics • September 14, 2015; (Issue 1477)
Implants, intrauterine devices (IUDs), and sterilization
are the most effective contraceptive methods available.
Pills, patches, rings, and injectables, when used
correctly, are also highly effective in...
Implants, intrauterine devices (IUDs), and sterilization
are the most effective contraceptive methods available.
Pills, patches, rings, and injectables, when used
correctly, are also highly effective in preventing pregnancy.
Barrier and fertility-based methods have the
highest rates of failure.
In Brief: Plan B One-Step OTC
The Medical Letter on Drugs and Therapeutics • June 24, 2013; (Issue 1419)
The progestin levonorgestrel is available over the counter for emergency contraception as two 0.75-mg tablets taken 12 hours apart (generic formulations of Plan B) and as a single 1.5-mg tablet taken once (Plan...
The progestin levonorgestrel is available over the counter for emergency contraception as two 0.75-mg tablets taken 12 hours apart (generic formulations of Plan B) and as a single 1.5-mg tablet taken once (Plan B One-Step, and generics). A third emergency contraceptive, ulipristal (Ella – Watson), is available with a prescription.1 It appears that, pursuant to a court order, Plan B One-Step (but not the generic products), which was previously available over the counter from a pharmacist only for women 17 years and older, will now be available directly from pharmacy shelves with no age restrictions.
EMERGENCY CONTRACEPTION — Currently used hormonal methods of emergency contraception, which apparently mainly prevent or delay ovulation, can prevent 50-80% of pregnancies.2 They should be started as soon as possible within 72 hours after unprotected intercourse. One study found that taking levonorgestrel as late as 120 hours after unprotected intercourse could still be effective.3
Many oral contraceptives can be used in doses suitable for emergency contraception. All are recommended for use in 2 doses 12 hours apart, but given the effectiveness of a single dose of levonorgestrel 1.5 mg in Plan B One-Step, taking the tablets all at once might be an option. Patients who vomit within 1 hour of administration can repeat the dose. A copper IUD inserted within 5 days after intercourse can also provide emergency contraception.
ADVERSE EFFECTS — Nausea and vomiting occur less frequently with levonorgestrel alone than with estrogen-progestin combinations. Headache, abdominal pain and breast tenderness have been reported with either progestin-only or combination oral contraceptives. No fetal malformations caused by unsuccessful use of hormones for emergency contraception have been reported.
1. Ella: a new emergency contraceptive. Med Lett Drugs Ther 2011; 53:3.
2. DT Baird. Emergency contraception: how does it work? Reprod Biomed Online 2009; 18 suppl 1:32.
3. H von Hertzen et al. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. Lancet 2002; 360:1803.
Download complete U.S. English article
EMERGENCY CONTRACEPTION — Currently used hormonal methods of emergency contraception, which apparently mainly prevent or delay ovulation, can prevent 50-80% of pregnancies.2 They should be started as soon as possible within 72 hours after unprotected intercourse. One study found that taking levonorgestrel as late as 120 hours after unprotected intercourse could still be effective.3
Many oral contraceptives can be used in doses suitable for emergency contraception. All are recommended for use in 2 doses 12 hours apart, but given the effectiveness of a single dose of levonorgestrel 1.5 mg in Plan B One-Step, taking the tablets all at once might be an option. Patients who vomit within 1 hour of administration can repeat the dose. A copper IUD inserted within 5 days after intercourse can also provide emergency contraception.
ADVERSE EFFECTS — Nausea and vomiting occur less frequently with levonorgestrel alone than with estrogen-progestin combinations. Headache, abdominal pain and breast tenderness have been reported with either progestin-only or combination oral contraceptives. No fetal malformations caused by unsuccessful use of hormones for emergency contraception have been reported.
1. Ella: a new emergency contraceptive. Med Lett Drugs Ther 2011; 53:3.
2. DT Baird. Emergency contraception: how does it work? Reprod Biomed Online 2009; 18 suppl 1:32.
3. H von Hertzen et al. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. Lancet 2002; 360:1803.
Download complete U.S. English article
Ella: A New Emergency Contraceptive
The Medical Letter on Drugs and Therapeutics • January 10, 2011; (Issue 1355)
The FDA has approved the use of ulipristal acetate
(ella – Watson) as an emergency contraceptive that
can be taken up to 5 days after unprotected intercourse.
It is available only by...
The FDA has approved the use of ulipristal acetate
(ella – Watson) as an emergency contraceptive that
can be taken up to 5 days after unprotected intercourse.
It is available only by prescription.
In Brief: Plan B for 17-Year Olds
The Medical Letter on Drugs and Therapeutics • May 18, 2009; (Issue 1312)
The FDA has announced that it will lower the age for over-the-counter access to the emergency contraceptive Plan B1 from 18 to 17 years old. In a randomized, controlled trial, the two 0.75-mg levonorgestrel...
The FDA has announced that it will lower the age for over-the-counter access to the emergency contraceptive Plan B1 from 18 to 17 years old. In a randomized, controlled trial, the two 0.75-mg levonorgestrel tablets in Plan B, taken 12 hours apart beginning within 72 hours after unprotected intercourse, decreased the overall pregnancy rate to 1.1% (11/976) of women who requested emergency contraception.2 The sooner the drug is taken after coitus, the more effective it is. Nausea and vomiting can occur with Plan B. Fetal malformations have not been associated with pregnancies that occurred despite use of levonorgestrel-only emergency contraception.3
1. Emergency contraception OTC. Med Lett Drugs Ther 2004; 46:10.
2. Task Force on Postovulatory Methods of Fertility Regulation. Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Lancet 1998; 352:428.
3. L Zhang et al. Pregnancy outcome after levonorgestrel-only emergency contraception failure: a prospective cohort study. Hum Reprod 2009 Mar 31 (epub).
Download: U.S. English
1. Emergency contraception OTC. Med Lett Drugs Ther 2004; 46:10.
2. Task Force on Postovulatory Methods of Fertility Regulation. Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Lancet 1998; 352:428.
3. L Zhang et al. Pregnancy outcome after levonorgestrel-only emergency contraception failure: a prospective cohort study. Hum Reprod 2009 Mar 31 (epub).
Download: U.S. English
Choice of Contraceptives
The Medical Letter on Drugs and Therapeutics • December 1, 2007; (Issue 64)
Transdermal, transvaginal and intrauterine hormone delivery systems have made highly effective contraceptive products more convenient to use. New oral contraceptive options include regimens with fewer or...
Transdermal, transvaginal and intrauterine hormone delivery systems have made highly effective contraceptive products more convenient to use. New oral contraceptive options include regimens with fewer or shorter hormone-free intervals.
Choice of Contraceptives
The Medical Letter on Drugs and Therapeutics • August 1, 2004; (Issue 24)
In recent years, several new contraceptive options have become available in the United States. Novel hormone delivery systems such as transdermal, transvaginal and intrauterine devices have improved the...
In recent years, several new contraceptive options have become available in the United States. Novel hormone delivery systems such as transdermal, transvaginal and intrauterine devices have improved the convenience of highly effective contraceptive products. Like oral contraceptives and most barrier contraceptives, these devices do not protect against sexually transmitted diseases.
Emergency Contraception OTC
The Medical Letter on Drugs and Therapeutics • February 2, 2004; (Issue 1175)
An FDA Advisory Committee has recommended over-the-counter (OTC) marketing of Plan B (Barr), an emergency contraceptive "pill pack" that contains two 0.75-mg tablets of levonorgestrel to be taken 12 hours apart...
An FDA Advisory Committee has recommended over-the-counter (OTC) marketing of Plan B (Barr), an emergency contraceptive "pill pack" that contains two 0.75-mg tablets of levonorgestrel to be taken 12 hours apart (Medical Letter 2000; 42:10). Plan B is one of two FDA-approved products for this indication. The Preven Emergency Contraceptive Kit (Medical Letter, 40:102, 1998) includes four tablets, each containing 0.25 mg of levonorgestrel and 50 ╡g of ethinyl estradiol; these are taken 2 at a time 12 hours apart (the "Yuzpe regimen") and are available only by prescription.